查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968382

人工智慧（AI）市场分析及2035年医疗保健产业预测：按类型、产品、服务、技术、组件、应用、最终用户、部署、解决方案和模式划分

AI in Healthcare Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Deployment, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 456 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，医疗保健领域的人工智慧市场规模将从2024年的160亿美元成长至8,568亿美元，复合年增长率约为48.9%。该市场涵盖将人工智慧技术融入医疗保健领域，以改善诊断、治疗方案製定和患者管理。透过利用机器学习、自然语言处理和机器人技术，该领域正在推动临床疗效和营运效率的提升。对个人化医疗和预测分析日益增长的需求正在推动市场成长，并促进疾病检测、药物研发和虚拟医疗助理领域的创新。

受机器学习和数据分析技术进步的推动，医疗保健领域的人工智慧市场预计将迎来强劲成长。在该领域，临床试验板块正透过利用人工智慧技术提升患者招募效率和简化数据分析流程，实现领先成长。放射学领域也紧随其后，人工智慧驱动的影像解决方案提高了诊断的准确性和效率。预测分析子板块发展势头强劲，为医疗服务提供者提供可操作的洞察，以改善患者照护并提升营运效率。虚拟助理和聊天机器人的日益普及有助于简化病人参与和行政管理工作。人工智慧演算法驱动的个人化医疗正在变革治疗通讯协定，实现根据个别基因谱量身定制的干预措施。人工智慧驱动的药物发现也是一个前景广阔的领域，能够加速潜在化合物的识别并缩短上市时间。随着人工智慧不断融入医疗保健系统，伦理考量和资料隐私仍然至关重要，需要建立健全的框架来确保合规性和信任。

市场区隔
类型 机器学习、自然语言处理、电脑视觉、机器人流程自动化
产品 人工智慧驱动的穿戴式装置、诊断系统、治疗设备和虚拟助理。
服务 临床工作流程支援、预测分析、远端监控、资料管理
科技 深度学习、神经网路、认知运算、情境感知处理
成分 软体、硬体和服务
目的 病患管理、药物研发、医学影像、基因组学
最终用户 医院、诊所、研究机构、医疗保健提供者
发展 云端部署、本地部署、混合部署
解决方案 病患资料分析、临床试验、社区医疗保健管理、诈欺检测
模式 全自动、半自动、手动

市场概况：

在对可扩展、灵活的医疗数据管理的需求驱动下，医疗保健领域的人工智慧正在经历快速发展，其中基于云端的解决方案占据了相当大的市场份额。定价策略竞争激烈，符合医疗服务提供者成本效益目标的价值导向模式正日益受到青睐。近期发布的产品专注于提高诊断准确性和个人化医疗，体现了该行业对创新的坚定承诺。北美地区继续引领人工智慧的应用，但亚太地区投资的激增凸显了其作为主要参与者的新兴潜力。竞争基准分析显示，IBM、微软和谷歌等公司凭藉其技术实力和策略伙伴关係关係处于行业领先地位。北美和欧洲的法规结构至关重要，严格的资料隐私法影响市场动态。遵守医疗标准的需求进一步塑造了市场格局，并影响着人工智慧的应用策略。儘管面临资料安全和整合复杂性等挑战，但市场前景依然光明，人工智慧驱动的预测分析和精准医疗有望推动成长。

主要趋势和驱动因素：

受个人化医疗和先进诊断技术需求不断增长的推动，医疗保健领域的人工智慧市场正经历强劲成长。关键趋势包括人工智慧与远端医疗平台的日益整合，从而改善远端患者监护和医疗服务品质。穿戴式健康设备的普及也加速了人工智慧的应用，透过即时数据分析和预测性洞察，能够改善患者预后。医疗保健领域巨量资料分析的兴起是另一个重要驱动因素，它能够实现更精准的疾病预测和治疗方案製定。此外，人工智慧驱动的机器人手术也备受关注，因为它能够实现精准手术并缩短恢復时间。监管支援和政府主导的人工智慧应用推广措施也促进了市场扩张。开发用于慢性病管理的人工智慧解决方案蕴藏着许多机会，有助于应对糖尿病和心血管疾病等慢性病日益沉重的负担。专注于人工智慧驱动的药物发现和开发的公司能够更好地发挥市场潜力。此外，科技公司与医疗服务提供者之间的合作正在推动创新，并为变革性的医疗保健解决方案铺平道路。随着行业的不断发展，在技术进步和对以患者为中心的护理日益重视的推动下，医疗领域的人工智慧市场预计将持续成长。

压制与挑战：

人工智慧在医疗保健领域的市场目前面临许多重大限制和挑战。其中一个主要挑战是严格的法规环境。遵守医疗保健法规和标准既复杂又耗时，往往导致人工智慧应用的延迟。资料隐私问题也是一个主要障碍。在利用人工智慧技术的同时保护病患资讯需要强大的安全措施，而这些措施成本高且技术难度高。此外，熟练专业人员的短缺也是一大挑战。将人工智慧融入医疗保健需要同时具备技术和医学方面的专业知识，而这类人才目前十分稀缺。高昂的实施成本也是阻碍市场成长的因素之一。人工智慧技术所需的初始投资可能成为许多医疗保健机构的障碍。最后，医疗产业内部存在着变革阻力。传统方法根深蒂固，对新技术的接受度普遍较低，这可能会减缓人工智慧的普及速度。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 机器学习
    • 自然语言处理
    • 电脑视觉
    • 机器人流程自动化
  • 市场规模及预测：依产品划分
    • 人工智慧驱动的可穿戴设备
    • 诊断系统
    • 治疗设备
    • 虚拟助手
  • 市场规模及预测：依服务划分
    • 临床工作流程支持
    • 预测分析
    • 远端监控
    • 资料管理
  • 市场规模及预测：依技术划分
    • 深度学习
    • 神经网路
    • 认知运算
    • 情境感知处理
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
    • 服务
  • 市场规模及预测：依应用领域划分
    • 病患管理
    • 药物发现
    • 医学影像
    • 基因组学
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊所
    • 研究机构
    • 医疗保健提供者
  • 市场规模及预测：依市场细分
    • 基于云端的
    • 现场
    • 杂交种
  • 市场规模及预测：按解决方案划分
    • 患者数据分析
    • 临床试验
    • 人口健康管理
    • 诈欺侦测
  • 市场规模及预测：按模式
    • 自动的
    • 半自动
    • 手动的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Zebra Medical Vision
  • Tempus
  • PathAI
  • Qventus
  • Viz.ai
  • Aidoc
  • Butterfly Network
  • Babylon Health
  • Proscia
  • Owkin
  • Freenome
  • SOPHiA GENETICS
  • HeartFlow
  • Atomwise
  • Deep Genomics
  • Insilico Medicine
  • CureMetrix
  • Arterys
  • Recursion Pharmaceuticals
  • Enlitic

第九章 关于我们

简介目录
Product Code: GIS33043

AI in Healthcare Market is anticipated to expand from $16 billion in 2024 to $856.8 billion by 2034, growing at a CAGR of approximately 48.9%. The AI in Healthcare Market encompasses the integration of artificial intelligence technologies within medical practices, enhancing diagnostics, treatment planning, and patient management. This sector leverages machine learning, natural language processing, and robotics to improve clinical outcomes and operational efficiency. Rising demand for personalized medicine and predictive analytics is propelling market growth, fostering innovations in disease detection, drug discovery, and virtual health assistants.

The AI in Healthcare Market is poised for robust growth, propelled by advancements in machine learning and data analytics. Within this landscape, the clinical trials segment emerges as a top performer, leveraging AI to enhance patient recruitment and streamline data analysis. Radiology follows closely, with AI-driven imaging solutions improving diagnostic accuracy and efficiency. The predictive analytics sub-segment is gaining momentum, offering healthcare providers actionable insights for patient care and operational efficiency. Virtual assistants and chatbots are also witnessing increased adoption, enhancing patient engagement and administrative functions. Personalized medicine, powered by AI algorithms, is transforming treatment protocols, tailoring interventions to individual genetic profiles. AI-driven drug discovery is another promising area, accelerating the identification of potential compounds and reducing time-to-market. As AI continues to integrate into healthcare systems, ethical considerations and data privacy remain critical, necessitating robust frameworks to ensure compliance and trust.

Market Segmentation
TypeMachine Learning, Natural Language Processing, Computer Vision, Robotic Process Automation
ProductAI-Powered Wearables, Diagnostic Systems, Therapeutic Devices, Virtual Assistants
ServicesClinical Workflow Assistance, Predictive Analytics, Remote Monitoring, Data Management
TechnologyDeep Learning, Neural Networks, Cognitive Computing, Context-Aware Processing
ComponentSoftware, Hardware, Services
ApplicationPatient Management, Drug Discovery, Medical Imaging, Genomics
End UserHospitals, Clinics, Research Institutes, Healthcare Providers
DeploymentCloud-Based, On-Premises, Hybrid
SolutionsPatient Data Analysis, Clinical Trials, Population Health Management, Fraud Detection
ModeAutomated, Semi-Automated, Manual

Market Snapshot:

AI in Healthcare is witnessing a dynamic evolution with significant market share held by cloud-based solutions, driven by the demand for scalable and flexible healthcare data management. Pricing strategies remain competitive, with value-based models gaining traction as they align with healthcare providers' cost-efficiency goals. Recent product launches focus on enhancing diagnostic accuracy and personalized medicine, reflecting the industry's commitment to innovation. North America continues to lead in adoption, while Asia-Pacific's investment surge highlights its emerging potential as a key player. Competitive benchmarking reveals that companies like IBM, Microsoft, and Google are at the forefront, leveraging their technological prowess and strategic partnerships. Regulatory frameworks in North America and Europe are pivotal, with stringent data privacy laws influencing market dynamics. The landscape is further shaped by the need for compliance with healthcare standards, impacting AI deployment strategies. The market's trajectory is promising, with AI-driven predictive analytics and precision medicine expected to catalyze growth, despite challenges like data security and integration complexities.

Geographical Overview:

The AI in Healthcare market is witnessing remarkable growth across various regions, each characterized by unique dynamics. North America leads, driven by advanced healthcare infrastructure and substantial investments in AI technologies. The presence of major tech companies and healthcare institutions is fostering innovation and adoption. Europe follows, with strong emphasis on AI research and development, supported by government initiatives and funding. This region's commitment to data privacy enhances market attractiveness. In Asia Pacific, rapid expansion is driven by technological advancements and significant investments in AI healthcare solutions. The growing population and increasing healthcare demands further fuel this growth. Latin America and the Middle East & Africa are emerging as promising markets. In Latin America, rising investments in healthcare infrastructure and AI technologies are evident. Meanwhile, the Middle East & Africa are recognizing AI's potential in transforming healthcare services, enhancing efficiency and accessibility, and driving economic growth.

Key Trends and Drivers:

The AI in Healthcare Market is experiencing robust growth, fueled by the increasing demand for personalized medicine and advanced diagnostics. Key trends include the integration of AI with telemedicine platforms, enhancing remote patient monitoring and care delivery. The proliferation of wearable health devices is also driving AI adoption, enabling real-time data analysis and predictive insights for better patient outcomes. The rise of big data analytics in healthcare is another significant driver, allowing for more accurate disease prediction and treatment planning. Additionally, AI-powered robotic surgeries are gaining traction, offering precision and reduced recovery times. Regulatory support and government initiatives promoting AI adoption in healthcare further bolster market expansion. Opportunities abound in the development of AI solutions for chronic disease management, addressing the growing burden of conditions such as diabetes and cardiovascular diseases. Companies focusing on AI-driven drug discovery and development are well-positioned to capitalize on the market's potential. Moreover, partnerships between tech firms and healthcare providers are fostering innovation, paving the way for transformative healthcare solutions. As the industry evolves, the AI in Healthcare Market is poised for sustained growth, driven by technological advancements and an increasing focus on patient-centric care.

Restraints and Challenges:

The AI in Healthcare Market is currently facing several notable restraints and challenges. One significant challenge is the stringent regulatory environment. Compliance with healthcare regulations and standards is complex and time-consuming, often delaying AI implementation. Data privacy concerns also pose a major obstacle. Protecting patient information while utilizing AI technologies requires robust security measures, which can be costly and technically challenging. Additionally, there is a shortage of skilled professionals. The integration of AI into healthcare demands expertise in both technology and medical fields, which is currently lacking. High implementation costs further hinder market growth. The initial investment required for AI technologies can be prohibitive for many healthcare providers. Lastly, there is a resistance to change within the healthcare industry. Traditional practices are deeply ingrained, and there is often skepticism towards adopting new technologies, which can slow down AI adoption.

Key Players:

Zebra Medical Vision, Tempus, PathAI, Qventus, Viz.ai, Aidoc, Butterfly Network, Babylon Health, Proscia, Owkin, Freenome, SOPHiA GENETICS, HeartFlow, Atomwise, Deep Genomics, Insilico Medicine, CureMetrix, Arterys, Recursion Pharmaceuticals, Enlitic

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Machine Learning
    • 4.1.2 Natural Language Processing
    • 4.1.3 Computer Vision
    • 4.1.4 Robotic Process Automation
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 AI-Powered Wearables
    • 4.2.2 Diagnostic Systems
    • 4.2.3 Therapeutic Devices
    • 4.2.4 Virtual Assistants
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Clinical Workflow Assistance
    • 4.3.2 Predictive Analytics
    • 4.3.3 Remote Monitoring
    • 4.3.4 Data Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Deep Learning
    • 4.4.2 Neural Networks
    • 4.4.3 Cognitive Computing
    • 4.4.4 Context-Aware Processing
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Patient Management
    • 4.6.2 Drug Discovery
    • 4.6.3 Medical Imaging
    • 4.6.4 Genomics
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Clinics
    • 4.7.3 Research Institutes
    • 4.7.4 Healthcare Providers
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 Cloud-Based
    • 4.8.2 On-Premises
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Patient Data Analysis
    • 4.9.2 Clinical Trials
    • 4.9.3 Population Health Management
    • 4.9.4 Fraud Detection
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Semi-Automated
    • 4.10.3 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Deployment
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Deployment
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Deployment
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Deployment
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Deployment
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Deployment
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Deployment
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Deployment
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Deployment
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Deployment
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Deployment
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Deployment
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Deployment
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Deployment
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Deployment
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Deployment
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Deployment
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Deployment
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Deployment
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Deployment
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Deployment
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Deployment
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Deployment
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Deployment
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zebra Medical Vision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Tempus
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 PathAI
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Qventus
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Viz.ai
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Butterfly Network
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Babylon Health
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Proscia
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Owkin
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Freenome
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 SOPHiA GENETICS
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 HeartFlow
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Atomwise
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Deep Genomics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Insilico Medicine
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 CureMetrix
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Arterys
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Recursion Pharmaceuticals
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Enlitic
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us